Clinical study of Jinshuibao Capsule to improve ivF-ET pregnancy outcome in infertile patients with renal deficiency and ovarian reserve dysfunctio

Phase 4

• Conditions: Infertility associated with ovarian dysfunction

• Registration Number: ITMCTR2000003948
• Lead Sponsor: China Welfare Association International Peace Maternal and Child Health Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: Female
• Target Recruitment: Not specified

Inclusion Criteria

(1) The age range is 18 to 39;
(2) It conforms to the diagnostic criteria of western medicine and Chinese medicine at the same time;
(3) All planned to perform IVF-ET transplantation in the Reproductive Center of The International Peace Maternal and Child Health Center of China Welfare Association (ADOPT GNRH-A ultra-long natural cycle freeze-thawed embryo transplantation D3);
(4) those who have not taken medication or have taken medication but have stopped taking medication for more than 3 months;
(5) Volunteer to participate in this clinical study and sign the relevant informed consent.

Exclusion Criteria

(1) Any contraindications in accordance with IVF-ET and its derived technologies shall be excluded;
(2) Those who have used hormone drugs in recent 3 months;
(3) Infertility caused by ovulation disorders, immune factors and chromosomal abnormalities;
(4) Abnormal analysis of male semen;
(5) Persons with a history of severe drug allergy;
(6) Patients with breast or other reproductive organ diseases, such as multiple uterine fibroids, polycystic ovary syndrome, endometriosis, malformation of reproductive organs or physiological defects, or those with serious medical diseases;
(7) People who are allergic to multiple drugs or have known allergies to the components of this drug;
(8) Participating in other clinical trial projects.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
clinical pregnancy rate;

Secondary Outcome Measures

Name	Time	Method
laboratory index;clinical symptoms;